Author:
Lundberg Frida E.,Birgisson Helgi,Engholm Gerda,Ólafsdóttir Elínborg J.,Mørch Lina Steinrud,Johannesen Tom Børge,Pettersson David,Lambe Mats,Seppä Karri,Lambert Paul C.,Johansson Anna L.V.,Hölmich Lisbet Rosenkrantz,Andersson Therese M.-L.
Reference46 articles.
1. Bray F., Ferlay J., Soerjomataram I., et al. Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
2. Trends in cancer survival in the Nordic countries 1990-2016: the NORDCAN survival studies;Lundberg;Acta Oncol,2020
3. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964–2003 followed up to the end of 2006;Tryggvadóttir;Acta Oncol,2010
4. Larønningen S., Arvidsson G., Bray F., Engholm G., Ervik M., Guðmundsdóttir E.M., Gulbrandsen J., Hansen H.L., Hansen H.M., Johannesen T.B., Kristensen S., Kristiansen M.F., Lam F., Laversanne M., Miettinen J., Mørch L.S., Ólafsdóttir E., Pejicic S., Petterson D., Steig B.Á., Skog A., Tian H., Aagnes B., Storm H.H. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 9.3 (02.10.2023). Association of the Nordic Cancer Registries. Cancer Registry of Norway. 2023. https://nordcan.iarc.fr/.
5. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual;Gershenwald;CA Cancer J Clin,2017